Literature DB >> 32572679

Prof. Cristobal dos Remedios and the Sydney Heart Bank: enabling translatable heart failure research.

Joshua B Holmes1, Julian E Stelzer2.   

Abstract

Entities:  

Year:  2020        PMID： 32572679      PMCID： PMC7429574          DOI： 10.1007/s12551-020-00711-7

Source DB:  PubMed          Journal:  Biophys Rev        ISSN： 1867-2450


× No keyword cloud information.
  12 in total

Review 1.  Lost in translation: Interpreting cardiac muscle mechanics data in clinical practice.

Authors:  Ranganath Mamidi; Jiayang Li; Chang Yoon Doh; Joshua B Holmes; Julian E Stelzer
Journal:  Arch Biochem Biophys       Date:  2018-12-18       Impact factor: 4.013

2.  A step towards understanding the molecular nature of human heart failure: advances using the Sydney Heart Bank collection.

Authors:  Amy Li; Sean Lal; Cristobal G Dos Remedios
Journal:  Biophys Rev       Date:  2019-03-20

Review 3.  Regulating myofilament power: The determinant of health.

Authors:  Laurin M Hanft; Kerry S McDonald
Journal:  Arch Biochem Biophys       Date:  2019-01-10       Impact factor: 4.013

4.  Clinical development success rates for investigational drugs.

Authors:  Michael Hay; David W Thomas; John L Craighead; Celia Economides; Jesse Rosenthal
Journal:  Nat Biotechnol       Date:  2014-01       Impact factor: 54.908

5.  Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-C.

Authors:  Ranganath Mamidi; Kenneth S Gresham; Amy Li; Cristobal G dos Remedios; Julian E Stelzer
Journal:  J Mol Cell Cardiol       Date:  2015-06-20       Impact factor: 5.000

6.  Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardium.

Authors:  Ranganath Mamidi; Jiayang Li; Kenneth S Gresham; Sujeet Verma; Chang Yoon Doh; Amy Li; Sean Lal; Cristobal G Dos Remedios; Julian E Stelzer
Journal:  Circ Heart Fail       Date:  2017-10       Impact factor: 8.790

Review 7.  Strategies for targeting the cardiac sarcomere: avenues for novel drug discovery.

Authors:  Joshua B Holmes; Chang Yoon Doh; Ranganath Mamidi; Jiayang Li; Julian E Stelzer
Journal:  Expert Opin Drug Discov       Date:  2020-02-18       Impact factor: 6.098

Review 8.  Small and large animal models in cardiac contraction research: advantages and disadvantages.

Authors:  Nima Milani-Nejad; Paul M L Janssen
Journal:  Pharmacol Ther       Date:  2013-10-15       Impact factor: 12.310

Review 9.  The Sydney Heart Bank: improving translational research while eliminating or reducing the use of animal models of human heart disease.

Authors:  W Linke; C G Dos Remedios; S P Lal; A Li; J McNamara; A Keogh; P S Macdonald; R Cooke; E Ehler; R Knöll; S B Marston; J Stelzer; H Granzier; C Bezzina; S van Dijk; F De Man; G J M Stienen; J Odeberg; F Pontén; J van der Velden
Journal:  Biophys Rev       Date:  2017-08-14

Review 10.  Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials.

Authors:  Tariq Ahmad; P Elliott Miller; Megan McCullough; Nihar R Desai; Ralph Riello; Mitchell Psotka; Michael Böhm; Larry A Allen; John R Teerlink; Giuseppe M C Rosano; Joann Lindenfeld
Journal:  Eur J Heart Fail       Date:  2019-08-13       Impact factor: 15.534
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.